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     INTRODUCTION 
  Leptospirosis is an acute febrile illness caused by patho-
genic species belonging to the genus   Leptospira . This  zoonotic 
disease has a worldwide distribution, but has the greatest 
impact on health in developing countries where it is often 
grossly under-recognized. Clinical features are similar to a 
range of other infectious diseases that occur in the same geo-
graphic regions, including scrub typhus, dengue, and malaria.  1  
Accurate laboratory diagnosis of leptospirosis is important for 
correct patient management, but there is a paucity of diagnos-
tic tests that provide timely information around the time of 
admission. Culture can be performed during the first week of 
symptoms but is rarely undertaken because it requires con-
siderable expertise, is time-consuming, and may not provide a 
positive result for weeks or months. 
  The microscopic agglutination test (MAT) is commonly 
used as a serologic diagnostic gold standard. This test relies on 
detecting an increase in antibody titer between serum samples 
obtained at least two weeks apart and provides a retrospective 
diagnosis that is useful for epidemiologic purposes but does 
not benefit individual patient management. Conventional and 
real-time polymerase chain reactions have been described 
for detection of pathogenic   Leptospira   in blood at the time 
of patient presentation,  2–  5   and are useful for investigation of 
patients presenting within the first week of illness (during the 
leptospiremic phase of infection) in settings that have the nec-
essary equipment and trained laboratory personnel. However, 
these assays are not in routine use in many countries where lep-
tospirosis is highly endemic because the equipment required 
is costly, and performing the assay to the required standard 
demands considerable expertise and training. 
  Loop-mediated isothermal amplification (LAMP) is an 
alternative method of rapid DNA amplification. The final 
products are stem-loop DNAs with several inverted repeats of 
the target and cauliflower-like structures with multiple loops 
formed by annealing between alternately inverted repeats 
of the target in the same strand.  6   The reaction results in the 
accumulation of 10  9   copies of target and simply requires a 
laboratory water bath or heating block to maintain a con-
stant temperature of 60–65°C, making it particularly suited 
to lower-technology settings. The LAMP has been developed 
for detection of a range of pathogenic bacteria and viruses,  7–  9  
including   Leptospira   species. 10   The published   Leptospira   assay 
targets   lipL41  , a gene encoding the outer membrane protein 
LipL41, which is expressed by pathogenic   Leptospira . 11   The 
lower limit of detection was reported to be approximately 100 
genomic equivalents (GEs) per reaction, and the assay was 
specific for   Leptospira   in a laboratory evaluation. The assay 
detected   Leptospira   in seven mouse kidney samples obtained 
from animals captured during environmental surveillance,  10  
but has not undergone clinical evaluation to date. 
  Leptospira   genomes contain two 16S ribosomal RNA genes 
for which there are multiple sequences of variable length in 
public databases, phylogenetic analysis of which has identi-
fied three clades within the genus composed of the pathogenic 
species, non-pathogenic species, and a clade with intermediate 
16S ribosomal RNA gene sequence relatedness.  12   The  latter 
group is considered to represent opportunistic/intermediate 
pathogens, although there are an increasing number of reports 
associating them with human leptospirosis.  13–  15   The  objective 
of this study was to use the phylogenetic distinctions inherent 
in the 16S ribosomal RNA gene sequence to develop an alter-
native LAMP assay (  rrs   LAMP) that can detect   Leptospira  
spp. in the pathogenic and intermediate groups, and to under-
take a clinical case–control evaluation of the diagnostic accu-
racy of   rrs   and   lipL41   LAMP in rural Thailand. 
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   MATERIALS AND  METHODS 
  Laboratory  strains.    The   rrs   LAMP was initially developed 
by using genomic DNA extracted from   L. interrogans   serovar 
Autumnalis strain L0551 isolated in 2001 from a patient in 
northeastern Thailand, and then further evaluated by using 
an additional 23   Leptospira   isolates shown in   Table 1  . The 
specificity of the assay for   Leptospira   spp. was evaluated by 
using one clinical isolate of each of the following bacterial 
species:   Staphylococcus aureus, Enterococcus   sp ., Escherichia 
coli, Salmonella enterica   serovar Typhi,   Klebsiella pneumoniae, 
Pseudomonas aeruginosa, Burkholderia pseudomallei, Orientia 
tsutsugamushi  strain Kato, and  Rickettsia typhi . Genomic DNA 
was extracted from laboratory cultures by using the Wizard  ®  
Genomic DNA Extraction Kit (Promega, Madison, WI) with 
the addition of 5 μL of lysostaphin (10 mg/mL) during the 
extraction of   S. aureus   DNA. 
        Primer  design.     A total of 39 sequences for the full-length 
16S ribosomal RNA gene of   Leptospira   spp. were downloaded 
from GenBank, of which 23 sequences were from 8 pathogenic 
  Leptospira   spp., 6 sequences were from 3 intermediate 
group   Leptospira   spp., and 10 sequences were from 6 non-
pathogenic   Leptospira   spp. Accession numbers are pathogenic 
species  Leptospira interrogans  (n = 10, accession nos. AY631894, 
AY996790, AY996791, AY996792, AY996893, AY996794, 
AY996796, AY996797, AY9967698, AY99680),   L. borgpe-
tersenii     (n = 2, accession nos.   AY631884,   AY887899),   L. kirsch-
neri   (n = 3, accession nos. AY631895, AY996801, AY996802), 
  L. alexanderi   (n = 3, accession nos. AY631880, AY996803, 
AY996804),   L. santarosai   (n = 2, accession nos. AY631883, 
AY996805),   L. noguchii   (n = 1, accession no. AY631886), 
  L. alstonii   (n = 1, accession no. AY631881),   L. weilii   (n = 1, 
accession no. AY631877); intermediate species   L. inadai   (n = 3, 
accession nos. AY631887, AY631891, AY631896),   L. broomii  
(n = 1, accession no. AY796065),   L. fainei   (n = 2, accession nos. 
AY631885, AY996789); and non-pathogenic species   L. biflexa  
(n = 2, accession nos. AY631876, AY631893),   L. meyeri   (n = 3, 
accession nos. AY631878, AY631889, AY631892),   L. wolbachii  
(n = 2, accession nos. AY631879, AY631890),   L. vanthielii  
(n = 1, accession no. AY631897),  L. terpstrae  (n = 1, accession no. 
AY631888), and  L. yanagawae  (n = 1, accession no. AY631882). 
The partial 16S ribosomal RNA sequence of three recently 
described   Leptospira   spp. were also included: pathogenic 
  L. kmetyi   (n = 1, accession no. AB279549) and intermediate 
group   L. licerasiae   (n = 9, accession nos. EF612280-8) and 
  L. wolffii   (n = 1, accession no. EF025496). 
  All sequences were aligned and compared by using Clustal 
X version 1.83  16   and Genedoc (  http://www.nrbsc.org/gfx/gene
doc/index.html ). 17   A set of five primers consisting of two outer 
primers (F3 and B3), two inner primers (forward inner primer 
FIP and backward inner primer BIP), and one loop primer 
(loop B (LBP)) were designed by using PrimerExplorer ver-
sion 4 (  http://primerexplorer.jp/e/  ). The target sequences were 
regions that were specific to the 16S ribosomal RNA gene 
sequence of all pathogenic and intermediate but not non-
pathogenic   Leptospira   spp., as shown in   Figure 1A  . Primers 
are shown in   Figure 1B  . 
    LAMP  assays.    The   lipL41   LAMP was performed by using 
primers and conditions described.  10  The   rrs   LAMP was carried 
out in a reaction mixture of 25 μL containing 5 pmol of each 
outer primer (F3, B3), 40 pmol of each inner primer (FIP, BIP), 
20 pmol of loop primer (LPB), 1× ThermoPol reaction buffer, 
0.8 M Betaine (Sigma, St. Louis, MO), 1.4 mM dNTP, 6 mM 
MgSO  4  , 8 units of   Bst   DNA polymerase, large fragment (New 
England Biolabs, Ipswich, MA), and 1 μL (approximately 
20–100 ng) of genomic DNA extracted from laboratory cultures 
of   Leptospira   spp. The reaction mixture was incubated at 63°C 
for 2 hours and then heated at 80°C for 5 minutes to terminate 
the reaction. The presence of product was defined for both 
 Table 1 
   Leptospira   spp. used in the study, Thailand  *     
Species Serogroup Serovar Strain
  L. interrogans Autumnalis Autumnalis L0551
  L. interrogans Autumnalis Autumnalis Akiyami  A
  L. interrogans Bataviae Bataviae Swart
  L. interrogans Djasiman Djasiman Djasiman
  L. interrogans Hebdomadis Hebdomadis Hebdomadis
  L. interrogans Icterohaemorrhagiae Lai Lai
  L. kirshneri Grippotyphosa Grippotyphosa Moskva
  L. kirschneri Cynopteri Cynopteri 3522C
  L. borgpetersenii Ballum Ballum Mus  127
  L. borgpetersenii  Javanica Javanica Veldrat Batavia 46
  L. santarosai Autumnalis Alice Alice
  L. alexanderi Manhao Manhao3 L60
  L. noguchii Autumnalis Fortbragg Fort  Bragg
  L. weilii Celledoni Celledoni Celledoni
  L. weilli Sarmin Sarmin Sarmin
  L. alstonii Ranarum Pingchang 80-412
  L. inadai Lyme Lyme 10
  L. biflexa  Semaranga Patoc I Patoc I
  L. wolffii Khorat Khorat H2
  L. meyeri  Ranarum Ranarum Iowa City Frog
  L. meyeri  Semaranga Semaranga Veldrat Semaranga 173
  L. wolbachii Codice Codice CDC
  L. terpstrae Icterohaemorrhagiae Hualin LT11-33
  L. yanagawae Semaranga Saopaulo Sao  Paulo
    *      Isolates were obtained from the World Health Organization/Food and Agriculture Organization of the United Nations/World Organisation for Animal Health Collaborating Centre for 
Reference and Research on Leptospirosis, Brisbane, Queensland Australia; the Bureau of Emerging Infection Disease, Ministry of Public Health, Bangkok, Thailand; the American Type Culture 
Collection, Manassas, Virigina; the Royal Tropical Institute (KIT), Amsterdam, The Netherlands; and Dr. Thareerat Kalambaheti (Mahidol University, Bangkok, Thailand).   616 SONTHAYANON AND OTHERS
LAMP assays on the basis of detecting a white precipitate with 
the naked eye after centrifugation at 13,000 ×   g   for 2 minutes. 
All results were confirmed by examining 3 μL of amplified 
products by using 2% agarose gel electrophoresis and staining 
with ethidium bromide. Positive and negative controls were 
genomic DNA from   L. interrogans   serovar Lai and reaction 
mixture without DNA, respectively. The analytical sensitivity 
of   rrs   LAMP was determined by using a 10-fold serial dilution 
(ranging from 2 × 10  6   to 0.02 GEs) of   L. interrogans   serovar 
Lai genomic DNA. The analytical specificity of this assay was 
determined by using DNA from non-pathogenic   Leptospira  
spp. and a range of other bacterial species. 
   Clinical  validation.     Patients with (cases) or without 
leptospirosis (controls) were selected from a prospective 
cohort of 418 patients with an acute febrile illness who came to 
the Udon Thani Regional Hospital in northeastern Thailand 
during January 10, 2001–June 16, 2002.  18   Briefly, patients 
were recruited into the study during twice a day ward rounds. 
Inclusion criteria were patients who were ≥ 15 years of age with 
fever (> 37.8°C) of unknown cause who agreed to participate 
 Figure  1 .      A  , Sequence alignment of a region of the 16S ribosomal RNA gene (  rrs  ) of 20   Leptospira   spp. to demonstrate the regions selected for 
primer design. The objective was to design primers that annealed to the target gene of   Leptospira   spp. that belonged to either the pathogenic (  white 
letters in black box  ) or intermediate group (  white letters in gray box  ), but that failed to anneal to the target gene of   Leptospira   spp. in the non-
pathogenic group (  black letters in gray box  ). F1c, F2, F3, B1, B2c, B3, and LPB refer to the names and locations of target sequences for the primers 
used.   B  , Sequences of   rrs   loop-mediated isothermal amplification (LAMP) primers. Primer FIP consisted of the F1complementary sequence (20 
nucleotides) and the F2 direct sequence (21 nucleotides). Primer BIP consisted of the B1 direct sequence (21 nucleotides) and the B2 complemen-
tary sequence (19 nucleotides).       617 LAMP AS A DIAGNOSTIC TOOL FOR LEPTOSPIROSIS
and to attend out-patient follow-up for a convalescent-phase 
serum sample. The exclusion criterion was the presence of a 
definable infection at the time of admission. 
  Blood was obtained on admission from all patients for 
  Leptospira   culture, serologic testing, and molecular diag-
nostics, and a second (convalescent-phase) sample was 
obtained for serologic testing approximately two weeks later. 
  Leptospira   culture was performed as described,  19   and isolates 
sent to the World Health Organization/Food and Agriculture 
Organization of the United Nations/World Organisation for 
Animal Health Collaborating Centre for Reference and 
Research on Leptospirosis Collaborating Center for Reference 
and Research on Leptospirosis (Brisbane, Queensland, 
Australia) for serovar identification by using the cross-agglu-
tinin absorption test.  20   The MAT was performed by the World 
Health Organization/Food and Agriculture Organization 
of the United Nations/World Organisation for Animal 
Health Collaborating Centre for Reference and Research 
on Leptospirosis as described  20   by using a live panel of anti-
gens representing ubiquitous and locally prevalent serovars. 
A diagnosis of leptospirosis was based on isolation of 
  Leptospira   from blood and/or a positive MAT result, which 
was defined as a four-fold increase in titer between acute-
phase and convalescence-phase samples or a single titer of 
≥ 1:400. Patients who did not meet these criteria were defined 
as not having current or recent leptospirosis. 
  All patients diagnosed as having leptospirosis during the 
prospective cohort study (n = 133) were selected as cases. 
Laboratory confirmation was made on the basis of culture-
positive and MAT-positive results in 21 (16%) patients, cul-
ture- positive results and MAT-negative results in 18 (13%) 
patients, and culture-negative results and MAT-positive 
results in 94 (71%) patients. A positive MAT result was based 
on a four-fold increasing titer in 97 cases and a single titer of 
≥ 1:400 in 27 cases. Controls (n = 133) were randomly selected 
from those patients who did not meet the diagnostic criteria 
for leptospirosis. Patients in this group had a convalescent-
phase serum sample obtained a median of 17 days (range = 
10–43 days, interquartile range [IQR] = 13–21 days) after the 
onset of symptoms. 
  A database was created in which cases and controls were 
entered, randomized, and blinded to the technician prior to 
performing the two LAMP assays. DNA was extracted from a 
5-mL blood sample (plus EDTA) obtained from cases and con-
trols on admission and stored at –80°C prior to use. Extraction 
was performed by using the Nucleon BACC 3 Kit B (GE 
Healthcare Biosciences, Piscataway, NJ), and the extract was 
suspended in 1 mL of Tris-EDTA buffer. The LAMP assays 
were described as above except that 5 μL of DNA extracted 
from whole blood was used per reaction. All patient samples 
were evaluated in duplicate for each of the two LAMP assays. 
A positive result for either one or both samples was inter-
preted as positive. 
  The study protocol was reviewed and approved by the 
Ethics Committee of the Faculty of Tropical Medicine, Mahidol 
University, Bangkok, Thailand. 
   Statistical  analysis.     Statistical analyses were performed by 
using STATA/SE version 10.0 (StataCorp., College Station, 
TX). Diagnostic sensitivity (DSe) and specificity (DSp) of 
each PCR assay was defined against the combined result for 
culture and MAT (a positive result for either or both being 
interpreted as diagnostic for leptospirosis), and expressed 
as a proportion with exact 95% confidence intervals (CIs). 
Comparison of DSe and DSp for the two LAMP assays was 
performed by using the McNemar test. The DSe of each assay 
was re-evaluated in the subset of patients who were culture 
positive. 
    RESULTS 
    Analytical sensitivity and specificity.     Primers were designed 
that were predicted to anneal to a region of   rrs   of   Leptospira  
spp. belonging to pathogenic and intermediate groups but 
not to the non-pathogenic group. The analytical specificity 
of these primers was assessed using genomic DNA extracted 
from 15   Leptospira   spp., including representatives of each 
of the three groups (  Figure 2  ) demonstrates confirmation of 
the expected annealing pattern. Specificity was further evalu-
ated by testing a range of bacterial species that commonly 
cause febrile illness in our patient population. No product 
was observed using genomic DNA from one isolate of 
each of the following bacteria:   S. aureus, Enterococcus   spp ., 
E. coli, S. enterica   serovar Typhi,   K. pneumoniae, P. aeruginosa, 
B. pseudomallei, O. tsutsugamushi  strain Kato, and  R. typhi . The 
analytical sensitivity (lower limit of detection) determined by 
using genomic DNA extracted from pure laboratory culture of 
  L. interrogans   serovar Lai was equivalent to10 GEs/reaction. 
        Diagnostic sensitivity and specificity of   rrs   LAMP.    In  total, 
133 patients with laboratory confirmed leptospirosis (cases) 
and 133 patients who did not have leptospirosis (controls) 
were evaluated. Patient recruitment and diagnostic testing 
are summarized in   Figure 3  . Of 133 patients, 18 (13%) were 
culture positive and MAT negative, 94 patients (71%) were 
MAT positive and culture negative, and 21 (16%) were MAT 
positive and culture positive. The median (IQR, range) age was 
35 years (26–46, 15–74 years) for cases and 42 years (29–54, 
15–79 years) for controls (  P   = 0.01). The median duration of 
illness prior to admission was 4 days (IQR = 2–5 days, range = 
1–12 days) for cases and 6 days (IQR = 3–9 days, range = 0–33 
days) for controls (  P   < 0.001). Most (120 of 133, 90.2%) of the 
case-patients came to the hospital with ≤ 7 days of the onset 
 Figure 2.        16S ribosomal RNA gene loop-mediated isothermal 
amplification products separated by 2% agarose gel electrophoresis. 
Lanes 1–8, pathogenic   Leptospira   spp. (  L. interrogans ,   L. kirshneri , 
  L. noguchii ,   L. alexanderi ,   L. weilli ,   L. borgpetersenii ,   L. santarosai , 
and   L. alstonii,   respectively); lanes 9 and 10, intermediate group 
  Leptospira   spp. (  L. inadai   and   L. wolffii  , respectively). No products 
were observed for non-pathogenic species (lanes 11–16,   L. biflexa , 
  L. meyeri ,   L. wolbachii ,   L. terpstrae ,   L. yanagawae  , and   Turneriella 
parva  , respectively). Lane M, 100-basepair DNA marker; lane 17, neg-
ative (no template) control.       618 SONTHAYANON AND OTHERS
of symptoms. Fourteen case-patients (11%) had received 
antimicrobial drug therapy that would be predicted to be 
bacteriocidal for   Leptospira   prior to blood sample collection. 
The discharge diagnoses of controls were as follows: scrub 
typhus (n = 54), other bacterial septicemia (n = 8),   E. coli  
(n = 2),   K. pneumoniae   (n = 2),   Acinetobacter baumanii   (n = 1), 
  Corynebacterium jeikeium   (n = 1),   Enterococcus   sp. (n = 1), 
  Streptococcus pneumoniae  (n = 1), dengue fever (n = 5), murine 
typhus (n = 4), melioidosis (n = 2), human immunodeficiency 
virus–related infections (n = 2), other diagnoses (n = 7), and 
unknown diagnosis (n = 51). Five cases (4%) and four controls 
(3%) died during hospital admission. 
  The   rrs   LAMP result was positive in 58 of 133 patients 
(DSe = 43.6, 95% CI = 35.0–52.5), and 22 of 133 controls 
(DSp = 83.5, 95% CI = 76.0–89.3). The diagnoses for the 22 
positive controls were scrub typhus (8), dengue (2), entero-
coccal septicemia (1), murine typhus (1), tuberculosis (1), and 
unknown (9). The duration of symptoms prior to presentation 
was significantly different between   rrs   LAMP-positive cases 
and   rrs   LAMP-negative cases (median = 3 days, IQR = 2–4 
days, range = 1–8 days versus median 4 days, IQR = 3–6 days, 
range = 1–12 days, respectively;   P   < 0.001). 
   Clinical  evaluation  of   lipL41   LAMP and comparison with 
  rrs   LAMP.    The   lipL41   LAMP result was positive in 50 of 
133 cases, (DSe = 37.6, 95% CI = 29.3–46.4), and 13 of 133 
controls (DSp = 90.2, 95% CI = 83.9–94.7). The diagnoses for 
these 13 positive controls were scrub typhus (4), dengue (2), 
eosinophilic meningitis (cause unknown) (1), murine typhus 
(1), and unknown (5). The differences in DSe and DSp values 
between the   rrs   and   lipL41   LAMP assays did not reach 
statistical significance (  P   = 0.13 and 0.06, respectively). 
  Concordance between the two assays was as follows. For 
cases, 43 were positive by both assays, 15 were positive by   rrs , 
and 7 were positive by   lipL41  . For controls, 8 were positive 
by both assays, 14 were positive by   rrs  , and 5 were positive by 
  lipL41 . 
      Sensitivity of LAMP assays in patients with leptospiremia.  
  Sensitivity was reanalyzed for 39 patients who were culture 
positive for   Leptospira   spp. The   rrs   LAMP result was positive 
in 33 patients (sensitivity = 84.6, 95% CI = 69.5–94.1), and the 
  lipL41   LAMP result was positive in 29 patients (sensitivity = 
74.4, 95% CI = 57.9–87.0) (  P   = 0.29). Six culture-positive 
patients were negative by both assays, and all culture-positive 
and LAMP-negative patients were infected with  L. interrogans  
serovar Autumnalis, the dominant cause of leptospirosis in 
Thailand during the study period.  21  
    DISCUSSION 
  The ease with which LAMP can be performed to detect 
pathogens in clinical samples has led to its development for 
major infectious diseases in the developing world, including 
tuberculosis and malaria.  22,  23   Most of the published literature 
on LAMP describes assay development and analytical sensi-
tivity and specificity, but relatively few studies have reported 
clinical evaluation of DSe and DSp. We developed an   rrs  
LAMP assay for the diagnosis of leptospirosis and demon-
strated 100% analytical sensitivity and specificity, and pro-
ceeded to a clinical evaluation by using samples obtained from 
a cohort of consecutive patients with an acute febrile illness 
who came to a hospital in northeastern Thailand. Having iden-
tified that the frequency of laboratory proven leptospirosis for 
this group was 18%, we elected to use a case–control design on 
the basis of cost. The DSe of  rrs  LAMP was disappointingly low 
(43.6%). The sensitivity of  rrs  LAMP for a subset of 39 patients 
who were culture positive for   Leptospira   spp. was considerably 
higher (84.6%). However, this observation has little practical 
utility because it is not possible to predict those patients with 
leptospiremia on the basis of clinical features alone. 
  A LAMP assay specific for   lipL41   has been developed pre-
viously for the diagnosis of leptospirosis and was included in 
our clinical evaluation. Possible reasons for the lower diag-
nostic sensitivity of   lipL41   LAMP compared with   rrs   LAMP 
include the difference in lower limit of detection for the two 
assays (10 GE/reaction and 100GE/reaction for   rrs   and   lipL41 , 
respectively), or infection with intermediate group   Leptospira  
spp., which would not be detected by   lipL41  . However, the 
latter possibility is not the case because all 39 isolates from 
patients who were culture positive have been identified and 
none belonged to the intermediate group. 
  There are several possible explanations for the low DSe of 
both LAMP assays. A wide range of oral antimicrobial drugs 
are available over the counter in Thailand, and it is common 
for persons to self-medicate in the period leading up to hospi-
tal admission. Many of the available antimicrobial drugs would 
be predicted to be effective against   Leptospira   spp., which may 
lead to a false-negative LAMP result although not necessarily 
a negative MAT result. We were aware that 14 case-patients 
had received an antimicrobial drug at the time of admission 
(of which 4 case-patients had positive results for both assays), 
but use of a drug may have been more common. The LAMP 
assays may have had false-negative results because the num-
ber of organisms in the sample was below the lower limit of 
detection for the assay, or because of failure of primer anneal-
ing, although we consider this unlikely for   rrs  , given the con-
served nature of the target. Although further refinements of 
the LAMP assay may result in an improvement in the lower 
limit of detection and diagnostic sensitivity, we are pessimistic 
that molecular tests will prove highly sensitive in unselected 
patients in settings where antibiotic use is uncontrolled. 
 Figure 3.        Patient recruitment and result of laboratory tests for 
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  The DSp of both LAMP assays were lower than antici-
pated, and it is possible that some of the LAMP-positive 
controls showed false-negative results by culture and MAT. 
The sensitivity of MAT is reported to be greater than 90%,  24  
and the finding in our study that 18 cases were culture posi-
tive but MAT negative highlights the imperfect sensitivity of 
MAT in our setting. The observation that 8 controls (with a 
diagnosis of scrub typhus [3], dengue [2], and unknown [3]) 
were positive by   rss   and   lipL41   assays is a further hint that 
these patients may have been leptospiremic. However, in the 
absence of definitive evidence to support true infection rather 
than another explanation such as laboratory contamination, 
we must assume that these cases had false-positive results 
rather than true positive results. 
  In conclusion, we have demonstrated that the   rss   LAMP 
can identify approximately half of patients with leptospirosis 
at the time of presentation in northeastern Thailand, but this 
finding is tempered by an imperfect specificity. We are unable 
to recommend use of LAMP in routine clinical practice 
until the results of additional clinical evaluations become 
available. 
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